VC258

Caenorhabditis elegans

CL6049

Caenorhabditis elegans

mboa-4

Caenorhabditis elegans

Predicted to enable acyltransferase activity. Predicted to be involved in lipid modification. Predicted to be located in membrane. Is an ortholog of human MBOAT1 (membrane bound O-acyltransferase domain containing 1) and MBOAT2 (membrane bound O-acyltransferase domain containing 2).

mboa-3

Caenorhabditis elegans

Predicted to enable acyltransferase activity. Predicted to be involved in lipid modification. Predicted to be located in membrane. Is an ortholog of human MBOAT1 (membrane bound O-acyltransferase domain containing 1) and MBOAT2 (membrane bound O-acyltransferase domain containing 2).

mboa-6

Caenorhabditis elegans

Predicted to enable 1-acylglycerophosphocholine O-acyltransferase activity and lysophospholipid acyltransferase activity. Involved in glycerophospholipid biosynthetic process; positive regulation of growth rate; and post-embryonic development. Predicted to be located in endoplasmic reticulum and membrane. Expressed in pharyngeal muscle cell and tail. Is an ortholog of human LPCAT3 (lysophosphatidylcholine acyltransferase 3).

tat-5

Caenorhabditis elegans

Predicted to enable ATPase-coupled intramembrane lipid transporter activity. Involved in embryo development. Located in cytoplasmic vesicle and plasma membrane. Expressed widely. Is an ortholog of human ATP9B (ATPase phospholipid transporting 9B (putative)).

XA8400

Caenorhabditis elegans

cds: F07F6.2

Caenorhabditis elegans

cds: C17H1.14

Caenorhabditis elegans